Report ID: SQMIG35B2089
Report ID:
SQMIG35B2089 |
Region:
Global |
Published Date: August, 2024
Pages:
219
|
Tables:
59 |
Figures:
75
North America dominated the endoscopy devices market in 2023, accounting for the largest revenue share at 41.0%. The high prevalence of many diseases, including gastrointestinal disorders, respiratory conditions, neurological problems, gynecological issues, and cancer, creates the need for endoscopic techniques for diagnosis and treatment disease. For example, according to a report by ResearchGate, there were estimated 2 million new cases of cancer and 611,720 cancer-related deaths in the US. in 2024. The number of candidates for minimally invasive procedures in various medical specialties including gastroenterology, nephrology, neurology, gynecology, and otolaryngology in the US. is driving demand for endoscopy. Also, the increasing prevalence of cancer, the increasing number of elderly populations, which is prone to chronic diseases requiring endoscopic treatment, and the increasing need for timely & early diagnosis will enter is leading to a search for endoscopy. About 26,890 new cases of stomach cancer and about 10,880 deaths from stomach cancer are expected in 2024, according to the American Cancer Society.
Asia Pacific is expected to be the fastest growing region in the market owing to rapidly developing healthcare, less stringent regulatory framework and economic growth that attracts foreign investment. The market is expected to grow owing to good initiatives by private players, such as training of healthcare professionals and increased investment in R&D to develop moving endoscopes. China’s endoscopy devices market accounted for the largest share in 2023. China has the largest population in the world and is one of the fastest growing economies. Increased collaboration among market players to develop advanced endoscopes is one of the key factors driving the market growth. For example, in July 2023, HOYA Group and PENTAX Medical announced the opening of a new office in Shanghai, China. The center is owned by PENTAX Medical Shanghai Co., Ltd. which will focus on endoscopy manufacturing, R&D and service for the market. The facility will produce PENTAX Medical’s endoscopy solutions tailored to the market.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35B2089